Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market
share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its
share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign
exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
exchange rate of the U.S. dollar that may cause an unfavorable foreign currency
exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and
Exchange Commission (t
Exchange Commission (the SEC).
ECIconnects, the membership community of ECI, provides learning through the
exchange of ideas and the
sharing of best practices in E&C
programs.
This privilege does not apply to
shares you buy and sell under our
exchange program.
If an award of stock options or stock appreciation rights expires or becomes unexercisable without having been exercised in full or is surrendered pursuant to an
exchange program or
shares issued through awards of restricted stock, restricted stock units, performance units, performance
shares, or stock - settled performance awards are forfeited to us or
If an Award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an
Exchange Program, or, with respect to Restricted Stock, Restricted Stock Units, Performance Units or Performance
Shares, is forfeited to or repurchased by the Company due to failure to vest, the unpurchased
Shares (or for Awards other than Options or Stock Appreciation Rights the forfeited or repurchased
Shares), which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated).
11-18-2005 2005 Drilling
Program Completed on Caledonia's Mulonga Plain Joint Venture 11-14-2005 Caledonia Mining 3rd Quarter Results 2005 10-13-2005 Available online: Webcast of presentation to the Minesite Forum 10-11-2005 London: Presentation to the Minesite Forum 09-14-2005 Caledonia amends terms of
share purchase warrants 09-13-2005 Caledonia and Motapa announce 11 drill targets at Mulonga Plain Kashiji Plain analytical results confirm possible local source 08-15-2005 Caledonia Mining signs a Memorandum of Understanding with a South African Black Economic Empowerment Consortium 08-12-2005 Caledonia Mining Second Quarter Results 2005 08-11-2005 Caledonia Mining Second Quarter Results Conference Call and Webcast 07-18-2005 Caledonia announces Summer Drilling
Program on Kikerk Lake Property, Nunavut 06-22-2005 Caledonia Mining Corporation announces Admission to the AIM Market of the London Stock
Exchange and # 1.57 million placing 06-13-2005 Caledonia Mining signs a Letter of Intent with a Cobalt Refinery to supply 3 % of total annual world production 05-16-2005 Caledonia Mining 1st Quarter Results 2005 05-06-2005 Caledonia Annual Meeting set for Tuesday May 10th 2005 05-05-2005 Caledonia Mining Granted Prospecting Right for Grasvally and Will Commence the Drilling
Program by Mid May 2005 03-29-2005 Caledonia Mining 4th Quarter and 2004 Annual Results 03-23-2005 Caledonia Mining Fourth Quarter and Annual results Conference call & webcast 03-08-2005 Mulonga Plain JV Exploration Work
Program Update 02-23-2005 Caledonia Mining Appoints New Chairman 01-31-2005 Caledonia updates diamond exploration results at Mulonga Plain joint venture in Zambia.
In the following chapter, I will issue a call to cancel several word - heavy evangelistic
programs, and
exchange them for a way of life that lives and
shares the gospel in a tangible way with others.
Governments, companies, and research institutions should accelerate
programs to
exchange information,
share know - how and good practice, and build technical capacity in food loss and waste prevention and reduction across the food supply chain.
The federal government will account for more than 63 percent of this total, or about $ 1.5 trillion, reflecting expanded Medicaid eligibility, premium and cost -
sharing subsidies through the Health Insurance Marketplaces (
exchanges), and growth in Medicare enrollment as baby boomers continue to enter the
program.
The
program provides foreign nationals with opportunities to participate in
exchange programs in the United States so they may return home to
share their experiences.
Add URL - Join our FREE links
exchange program for Russian sites: travel, dating, guides, news, and more with 45,000 unique visitors per month, we will be glad to
share our traffic with you.
The Institute has initiated numerous international
programs to promote
exchange of ideas, freedom of expression, and
shared resources.
In 1999, he created a software
program that allowed computer users to
share and
exchange files.
Some of those colleagues, Torres» cohortmates in the School Leadership
Program (SLP), praised Torres for her honest contributions to class,
sharing her own experiences both as a student and an educator, and encouraging the
exchange of feedback in an effort to help make herself and her classmates better leaders — and learners.
He created Project S.A.M.E. a US - Soviet Youth
Exchange that brought students from the US and USSR together to advocate for peace; founded Students Concerned about Bias in Society (SCABS) who fought for implementation of Title IX in Maine schools; directed the University of Maine Aspirations Project and launched 35 statewide student leadership teams to bring students» voices to educational reform; conducted
program evaluation research on the effects of the Maine Civil Rights Teams Project whose 50 student teams fought against bigotry and intolerance in Maine communities; founded the Center for School Climate and Learning and worked in hundreds of schools supporting students, teachers and administrators to bring youth voice to school reform in the US; co-authored two books, The Respectful School, and Transforming School Climate and Learning to
share what I have learned.
KDP Select, a lending
program that encourages self - published authors and publishers to make their work available exclusively in the Kindle Store for 90 - day periods in
exchange for a potential revenue
share, is part of that effort.
The libraries provide seeds specifically for their communities geographical location, and many have started seed -
sharing, or seed
exchanges, and offering gardening
programs around the seed
exchanges.
If a publisher signs on to this
program, the publisher agrees to
share weekly ««out the door» sales and returns quantities at an ISBN & channel level» in
exchange for the same information from the other participating publishers.
ProQuest and OCLC have announced the launch of a data
exchange program that will
share metadata across OCLC's Worldcat Local, ProQuest's Summon service, and the full text of ProQuest Central and ebrary e-books, enriching discoverability for users of each of these services.
The Templeton closed - end Funds referenced above, which trade on the New York Stock
Exchange, announced today that each Fund's Board has approved a modification to the Funds» existing open - market
share repurchase
programs to authorize each Fund to repurchase up to 10 % of a Fund's outstanding
shares in open - market transactions, at the discretion of management.
They're not offered now, but
shared - appreciation
programs might also be available, where investors
share in the appreciation of a home in
exchange for assistance at the purchase, Pickel said.
This privilege does not apply to
shares you buy and sell under our
exchange program.
Similar to the 13th Avenue Funding model, the Back a Boiler
program offers junior and senior Purdue University students the option to receive funding from the Purdue Research Foundation in
exchange for signing an income
share agreement (ISA).
This no - fee, no - commission reinvestment
program allows you to reinvest dividend and / or capital gains distributions from any or all eligible stocks, closed - end mutual funds,
exchange - traded funds (ETFs), FundAccess ® funds, or Vanguard mutual funds in your Vanguard Brokerage Account in additional
shares of the same securities.
US multi-asset brokerage Interactive Brokers (NASDAQ: IBKR) said its Canadian unit has launched a Stock Yields Enhancement
Program, under which clients can lend the broker
shares they own from companies listed on US
exchanges and earn money from that.
The
program, found on Facebook.com/RoyalCanin.us, encourages cat owners to «
share» information about spaying and neutering, in
exchange for free SPAYED / NEUTERED food samples.
Another great benefit of owning a fractional
share of the Lodges at Cannon Beach is being part of a world travel
exchange program.
E-Rewards is a
program that allows members to earn rewards in
exchange for completing surveys and
sharing their opinions.
A unique quality of the ThankYou
program is that you can
exchange share your points with anybody!
The Tourism Action Plan competition is a part of the training
program jointly held by the Korea Tourism Organisation and Yeungnam University so to
share knowledge and
exchange ideas in tourism development of the country.
Preferred Residences ™, a hospitality branded membership and
exchange program for luxury
shared ownership resorts offered by a subsidiary of Interval Leisure Group, today announced that The Cottages at Windermere House has joined its
exchange network.
Southwest frequent flyers have the ability to collect hundreds of reward points when they join e-Rewards, a
program that allows members to earn rewards in
exchange for completing surveys and
sharing their opinions.
The Chiaro Awardee will become part of the dynamic community of artists participating in Headlands»
programs,
sharing in peer - to - peer creative
exchange while developing his or her individual artistic practice.
She is a featured producer at the Public Radio
Exchange (PRX.ORG) where her work is commissioned and
shared with radio
programs and listeners globally.
Others seek to keep up a
program born out of subjective endeavours and
shared with a worldwide community: such as LIFE SPORT in Athens, which sells «critical wearables» — the LIFE SPORT joggers — as an attempt to generate alternative arts funding in a time and place where there is none; Opening Times, which is an online - only exhibition platform; Peach, an exhibition space and home in Rotterdam; and I: project space, which fills a gap in the Beijing art scene by presenting video art and supporting artist
exchange via residencies.
With a strong emphasis on communications, trainings, and
exchanges to
share best practices, the
program will catalyze zero waste commitments and initiatives in more cities.
Frank Momberg, Fauna and Flora International's Asia - Pacific director for
program development, told Reuters» David Fogarty that plantations companies have agreed to forgo converting rainforest areas in West Kalimantan on the island of Borneo in
exchange for a
share of the revenue generated from the sales of forest carbon credits.
By so doing, the
program acts as an
exchange between the regions, bringing together clean energy representatives to
share successes and develop the
program further.
Initially, we
exchanged emails to decide on the specific topic for the
program and then
shared bullet points we each felt were important to the discussion.
The
Exchange is a
program that convenes every five years to allow the United States and the United Kingdom to
share information as to legal developments on both sides of the ocean.
This rule also proposes additional standards related to essential health benefits, meaningful access in the
Exchange, consumer assistance tools and
programs of an
Exchange, non-Navigator assistance personnel, cost -
sharing parameters and cost -
sharing reduction notices, quality improvement strategy standards for issuers of qualified health plans participating in
Exchanges, guaranteed availability and guaranteed renewability, minimum essential coverage, the medical loss ratio Start Printed Page 70742
program, the Small Business Health Options
Program, and FFE user fees.
The
exchange provides its Affiliate
program with a quite appealing revenue
share mechanism.
Materials you
share with us will support knowledge
exchange across the country and support the day - to - day work of many Responsible Fatherhood
program professionals.
One of the ways RE / MAX Gateway attracts agents is through a real estate
exchange program it offers, where REALTORS ® from the area are invited to take part in an evening where a mortgage and title company speak, and people
share information.
I received a gift card in
exchange for
sharing about their great library
program (below), but my post and room are my own.